Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-16

FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

The FDA approved GlaxoSmithKline LLC's supplemental application for Ventolin HFA (albuterol sulfate) under NDA 020983, resulting in a regulatory update to the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VENTOLIN HFA (Albuterol sulfate)

Snippet

SUPPL AP for VENTOLIN HFA (ALBUTEROL SULFATE)